Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Triggle

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
Journal of Autonomic Pharmacology|June 1, 1984
Specific and non-specific desensitization of guinea-pig ileal smooth muscleH Siegel, K Jim, G T Bolger, et al.
Canadian Journal of Physiology and Pharmacology|July 1, 1987
Comparative aspects and temperature dependence of [3H]1,4-dihydropyridine Ca2+ channel antagonist and activator binding to neuronal and muscle membranesD Rampe, E Luchowski, A Rutledge, et al.
Biochemical Pharmacology|October 15, 1984
Comparison of high affinity binding of calcium channel blocking drugs to vascular smooth muscle and cardiac sarcolemmal membranesJ G Sarmiento, R A Janis, A M Katz, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
[3H]BAY K 8644, a 1,4-dihydropyridine Ca++ channel activator: characteristics of binding to high and low affinity sites in cardiac membranesJ G Sarmiento, A V Shrikhande, R A Janis, et al.
Journal of Computer-Aided Molecular Design|April 1, 1991
Molecular level model for the agonist/antagonist selectivity of the 1,4-dihydropyridine calcium channel receptorD A Langs, Y W Kwon, P D Strong, et al.
Molecular Pharmacology|October 1, 1994
L-type calcium channels: asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridinesR Bangalore, N Baindur, A Rutledge, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1990
The interactions of 1,4-dihydropyridines bearing a 2-(2-aminoethylthio)methyl substituent at voltage-dependent Ca2+ channels of smooth muscle, cardiac muscle and neuronal tissuesY W Kwon, Q Zhong, X Y Wei, et al.
Il Farmaco; Edizione Scientifica|July 1, 1978
Molecular properties of the adrenergic alpha-receptor. I--Structural requirements for specific covalent occupancy by N,N'-bis--(5-aminopentyl)cystamine derivativesY Ueda, C Melchiorre, B Lippert, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1984
Distinction between high-affinity [3H]phencyclidine binding sites and muscarinic receptors in guinea-pig ileum muscleE E El-Fakahany, D J Triggle, A T Eldefrawi, et al.
Journal of Medicinal Chemistry|August 17, 1999
Lipophilic 4-isoxazolyl-1,4-dihydropyridines: synthesis and structure-activity relationshipsN R Natale, M E Rogers, R Staples, et al.
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Journal of Autonomic Pharmacology|June 1, 1984
Specific and non-specific desensitization of guinea-pig ileal smooth muscleH Siegel, K Jim, G T Bolger, et al.
Canadian Journal of Physiology and Pharmacology|July 1, 1987
Comparative aspects and temperature dependence of [3H]1,4-dihydropyridine Ca2+ channel antagonist and activator binding to neuronal and muscle membranesD Rampe, E Luchowski, A Rutledge, et al.
Biochemical Pharmacology|October 15, 1984
Comparison of high affinity binding of calcium channel blocking drugs to vascular smooth muscle and cardiac sarcolemmal membranesJ G Sarmiento, R A Janis, A M Katz, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
[3H]BAY K 8644, a 1,4-dihydropyridine Ca++ channel activator: characteristics of binding to high and low affinity sites in cardiac membranesJ G Sarmiento, A V Shrikhande, R A Janis, et al.
Journal of Computer-Aided Molecular Design|April 1, 1991
Molecular level model for the agonist/antagonist selectivity of the 1,4-dihydropyridine calcium channel receptorD A Langs, Y W Kwon, P D Strong, et al.
Molecular Pharmacology|October 1, 1994
L-type calcium channels: asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridinesR Bangalore, N Baindur, A Rutledge, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1990
The interactions of 1,4-dihydropyridines bearing a 2-(2-aminoethylthio)methyl substituent at voltage-dependent Ca2+ channels of smooth muscle, cardiac muscle and neuronal tissuesY W Kwon, Q Zhong, X Y Wei, et al.
Il Farmaco; Edizione Scientifica|July 1, 1978
Molecular properties of the adrenergic alpha-receptor. I--Structural requirements for specific covalent occupancy by N,N'-bis--(5-aminopentyl)cystamine derivativesY Ueda, C Melchiorre, B Lippert, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1984
Distinction between high-affinity [3H]phencyclidine binding sites and muscarinic receptors in guinea-pig ileum muscleE E El-Fakahany, D J Triggle, A T Eldefrawi, et al.
Journal of Medicinal Chemistry|August 17, 1999
Lipophilic 4-isoxazolyl-1,4-dihydropyridines: synthesis and structure-activity relationshipsN R Natale, M E Rogers, R Staples, et al.
Pageof 15